SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,519,048 | +125.8% | 3,999,600 | +354.5% | 0.04% | +19.4% |
| Q2 2023 | $4,215,200 | -11.6% | 880,000 | +4.7% | 0.03% | +47.6% |
| Q1 2023 | $4,767,172 | +46.8% | 840,771 | +45.0% | 0.02% | -36.4% |
| Q4 2022 | $3,248,000 | +38.6% | 580,000 | +58.9% | 0.03% | +57.1% |
| Q3 2022 | $2,343,000 | -5.4% | 364,900 | -49.5% | 0.02% | +10.5% |
| Q2 2022 | $2,477,000 | +131.9% | 722,100 | +381.4% | 0.02% | +35.7% |
| Q1 2022 | $1,068,000 | +28.2% | 150,000 | +50.0% | 0.01% | +75.0% |
| Q4 2021 | $833,000 | -74.5% | 100,000 | -78.7% | 0.01% | -81.8% |
| Q3 2021 | $3,271,000 | – | 470,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |